Friday, December 05, 2025
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

who

Geneva, Sep 2 (Prensa Latina) The World Health Organization (WHO) warned today that the number of people with dementia grew throughout the world and there are more than 55 million persons.
Havana, Sep 2 (Prensa Latina) BioCubaFarma Business Group on Wednesday denied CNN´s information about alleged refusal from the World Health Organization (WHO) to certify Cuba's Covid-19 vaccines. The CNN aired on Wednesday that WHO refused authorization for the emergency use of Cuban vaccine candidate (Abdala), so it cannot be purchased through the Revolving Fund of the Pan American Health Organization (PAHO).
Geneva, Sep 1 (Prensa Latina) The World Health Organization (WHO) is currently monitoring the Mu variant (B.1.621) of SARS-CoV-2, classified so far as 'of interest.'
Geneva, Sep 1 (Prensa Latina) The World Health Organization (WHO) on Tuesday considered skepticism about the effectiveness of coronavirus vaccines as a serious issue, a position that hinders efforts to put an end to the Covid-19 pandemic.
Kabul, Aug 30 (Prensa Latina) A humanitarian corridor to Afghanistan started on Monday with the arrival of the first shipment of international medical aid to that country since it fell into the hands of the Taliban.
Ginegra, Aug 26 (Prensa Latina) Lambda, a SARS-CoV-2 variant reported for the first time in Peru, continues nowadays to be interest for the World Health Organization (WHO), although some experts consider it necessary to study in greater depth.
Bern, Aug 25 (Prensa Latina) Director General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, on Wednesday thanked Cuba for its concern in the fight against the spread of the Covid-19 pandemic.
Geneva, Aug 12 (Prensa Latina) The World Health Organization (WHO) announced Wednesday the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalized patients to test three new drugs (artesunate, imatinib and infliximabtres) in Covid-19 patients.